NCT05853887View on ClinicalTrials.gov

Liquid Biopsy Based NGS in Newly Diagnosed NSCLC

NARecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

August 15, 2025

Study Completion Date

December 31, 2025

Conditions
Non Small Cell Lung Cancer MetastaticNewly Diagnosed NSCLCNon-Squamous Non-Small Cell Neoplasm of Lung
Interventions
BEHAVIORAL

iNUDGE

Electronic health record nudge which prompts physicians to order plasma-based NGS testing for eligible patients with newly diagnosed lung cancer.

Trial Locations (6)

17602

RECRUITING

Penn Medicine Lancaster General Health, Lancaster

19104

RECRUITING

Penn Presbyterian Medical Center, Philadelphia

08003

RECRUITING

Penn Medicine Cherry Hill, Cherry Hill

08536

RECRUITING

Penn Medicine Princeton Health, Plainsboro

08080

RECRUITING

Penn Medicine Washington Township, Sewell

08043

RECRUITING

Penn Medicine Voorhees, Voorhees Township

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Charu Aggarwal

OTHER